[1] GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7.
[2] Han C, Liu F, Yang X, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504-514. doi: 10.1007/s11427-018-9281-6.
[3] Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi: 10.1186/s12933-018-0762-4.
[4] Zhang M, Wang B, Liu Y, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: The Rural Chinese Cohort Study. Cardiovasc Diabetol. 2017;16(1):30. doi: 10.1186/s12933-017-0514-x.
[5] Su WY, Chen SC, Huang YT, et al. Comparison of the Effects of Fasting Glucose, Hemoglobin A1c, and Triglyceride-Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus. Nutrients. 2019;11(11):2838. doi: 10.3390/nu11112838.
[6] Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, et al. Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. Int J Endocrinol. 2020; 2020:4678526. doi: 10.1155/2020/4678526.
[7] Lee SB, Ahn CW, Lee BK, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41. doi: 10.1186/s12933-018-0692-1.
[8] Zhao S, Yu S, Chi C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95. doi: 10.1186/s12933-019-0898-x.
[9] Irace C, Carallo C, Scavelli FB, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665-72. doi: 10.1111/ijcp.12124.
[10] Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189-97. doi: 10.1111/eci.12583.
[11] Ma X, Cui H, Sun M, et al. Fasting Blood Glucose, Cholesterol, and Risk of Primary Liver Cancer: The Kailuan Study. Cancer Res Treat. 2021. doi: 10.4143/crt.2020.817.
[12] Sun M, Wang W, Liu X, et al. Total cholesterol, alanine aminotransferase and the risk of primary liver cancer: A population-based prospective study. Medicine (Baltimore). 2021;100(18):e25746. doi: 10.1097/MD.0000000000025746.
[13] Ma X, Dong L, Shao Q, et al. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):31. doi: 10.1186/s12933-020-01006-7.
[14] Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989;20(10):1407-31. doi: 10.1161/01.str.20.10.1407.
[15] Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038.
[16] Wu S, An S, Li W, et al. Association of Trajectory of Cardiovascular Health Score and Incident Cardiovascular Disease. JAMA Netw Open. 2019;2(5):e194758. doi: 10.1001/jamanetworkopen.2019.4758.
[17] Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29(9):1037-57. doi: 10.1002/sim.3841.
[18] Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009;170(2):244-56. doi: 10.1093/aje/kwp107.
[19] Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58(4):783-7. doi: 10.1111/j.1532-5415.2010.02767.x.
[20] Wu S, Song Y, Chen S, et al. Blood Pressure Classification of 2017 Associated With Cardiovascular Disease and Mortality in Young Chinese Adults. Hypertension. 2020;76(1):251-258. doi: 10.1161/HYPERTENSIONAHA.119.14239.
[21] Li S, Guo B, Chen H, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci Rep. 2019;9(1):7320. doi: 10.1038/s41598-019-43776-5.
[22] Zhao Maoxiang, Song Lulu, Sun Lan et al. Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study. [J] .Diabetes Care, 2021, undefined: undefined.
[23] Janus A, Szahidewicz-Krupska E, Mazur G, Doroszko A. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders. Mediators Inflamm. 2016; 2016:3634948. doi: 10.1155/2016/3634948.
[24] Montagnani M, Golovchenko I, Kim I, et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem. 2002;277(3):1794-9. doi: 10.1074/jbc.M103728200.
[25] Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113(15):1888-904. doi: 10.1161/CIRCULATIONAHA.105.563213.
[26] Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A. 2000;97(4):1784-9. doi: 10.1073/pnas.97.4.1784.